查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813927

HIV自我检测市场规模、份额和趋势分析报告：按类型、技术、分销管道、地区和细分市场预测，2025-2033年

HIV Self-testing Market Size, Share & Trends Analysis Report By Type (Blood-based Kits, Saliva-based Kits), By Technology (Immunofiltration Assays, Lateral Flow Assays (LFA)), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

HIV自我检测市场摘要

预计 2024 年全球爱滋病毒自我检测市场规模为 2.1155 亿美元，到 2033 年将达到 6.4341 亿美元，2025 年至 2033 年的复合年增长率为 13.55%。

这项成长的驱动因素是：人们越来越重视早期爱滋病毒检测、爱滋病毒感染率不断上升，以及全球转向个人和保密的健康解决方案。

超过 100 个国家已经采取了 HIVST 政策，光是在 2023 年，全球就分发了超过 2,000 万套套件。快速诊断试剂套件价格实惠且扩充性，使其成为已开发国家和开发中国家卫生系统中必不可少的物品。根据最新估计，全球约有 4,080 万人感染爱滋病毒，其中包括 140 万名 0-14 岁儿童。光是 2024 年，就会有大约 130 万人新发生爱滋病毒感染，其中 12 万名为儿童。同年，估计将有 63 万人死于爱滋病毒相关原因，其中包括 7.5 万名儿童。自爱滋病毒流行以来，估计已有 4,410 万人死于爱滋病毒相关疾病。儘管影响持续存在，但过去十五年全球已取得长足进展。 2010年至2024年间，爱滋病毒新发感染人数下降了约40%，从每年220万例降至130万例。同期，爱滋病毒相关死亡人数下降了54%，从140万例降至63万例。这些下降反映了人们认识的提高和预防工作的加强、抗逆转录病毒疗法可及性的扩大，以及爱滋病毒自我检测等策略的采用，从而实现了更早的诊断和治疗。

HIV 自我检测市场强劲成长的驱动力之一是，人们对谨慎、便捷且易于使用的诊断方案的需求日益增长，尤其是在那些面临污名化和难以获得临床检测的人群中。根据联合国爱滋病规划署的数据，全球近 40% 的 HIV 感染者仍未被确诊，这主要是由于害怕歧视、社会污名化以及医疗资源匮乏。 HIV 自我检测提供了一种个人化的居家检测方案，使个人能够安心地了解自己的感染状况。像 OraQuick 家用 HIV 检测试剂盒这样的唾液检测套件因其非侵入性、简单性和 20 分钟即可出结果而广受欢迎。在 HIV 感染率最高的地区，例如撒哈拉以南非洲地区，自我检测至关重要。肯亚、马拉威和南非等国家已透过社区和非政府组织的推广，扩大了其国家 HIVST 计画。在高所得国家，电子商务的日益普及使得 HIV 自我检测可以透过线上药局广泛进行。这种匿名性、便利性和技术简易性的结合不仅提高了诊断率，而且从根本上改变了公共卫生系统处理爱滋病毒预防和治疗联繫的方式。

科技进步正在将爱滋病毒自检转变为更准确、更有效率、更以使用者为中心的流程。最常见的方法是侧流免疫检测(LFA)，它使用简单的试纸条从唾液或指尖采血样本中检测 HIV-1/2 抗体。这些检测方法可在 15-20 分钟内提供结果，而像 Atomo 的爱滋病毒自检仪这样的新设备则将采血针、缓衝液和试纸条等一体化整合系统整合在一个装置中。此外，与智慧型手机相连的数位自我检测仪正在试行中，使用者可以扫描结果、接收指导说明并使用远端医疗服务。临床试验显示，基于智慧型手机的读数与经过训练的目测判读的一致性超过 98%。此外，微流体和奈米检测的创新有望使未来的爱滋病毒检测试剂套件更加灵敏，并能更好地适应早期感染。该行业也正在转向组合试剂套件（例如，爱滋病毒 + 梅毒），尤其是在合併感染率高的地区。这种技术改进不仅可以减少人为错误，还可以使低识字率人群进行自我测试，进一步扩大全球采用率。

目录

第 1 章 HIV 自我检测市场：调查方法与范围

2. HIV自我检测市场：执行摘要

  • 市场概述
  • 类型和技术简介
  • 分销通路简介
  • 竞争格局简介

第三章 HIV 自我检测市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 市场驱动因素分析
    • 提高爱滋病毒认识和政府倡议
    • 对隐私和便利性有很高的要求
    • 检测套组的技术进步
  • 市场限制因素分析
    • 监管和核准挑战
    • 误用或误解的风险
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章：HIV自我检测市场：类型评估与趋势分析

  • HIV自我检测市场：类型变化分析
  • 血液试剂套件
  • 唾液试剂套件

第五章 HIV 自我检测市场：技术评估与趋势分析

  • HIV自我检测市场：技术变革分析
  • 免疫过滤试验
  • 横向流动化验（LFA）
  • 其他快速诊断技术

6. HIV自我检测市场：通路评估与趋势分析

  • HIV自我检测市场：通路变化分析
  • 零售及网路药局
  • 医院和诊断实验室
  • 非政府组织/社区分销

7. HIV自我检测市场：区域业务分析

  • 区域市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章 竞争态势

  • 公司分类
  • 战略地图
    • 新产品发布
    • 伙伴关係
    • 获得
    • 合作
    • 资金筹措
  • 2024年主要企业市占率分析
  • 公司热图分析
  • 公司简介
    • OraSure Technologies, Inc.
    • BioSURE HIVST
    • Atomo Diagnostics
    • Chembio Diagnostics, Inc.
    • SD Biosensor, INC.
    • CTK Biotech, Inc.
    • genedrive plc
    • Hydrex Diagnostics Sp.
    • Trinity Biotech
    • Abbott
Product Code: GVR-4-68040-710-7

HIV Self-testing Market Summary

The global HIV Self-testing market size was estimated at USD 211.55 million in 2024 and is expected to reach USD 643.41 million by 2033, growing at a CAGR of 13.55% from 2025 to 2033. This growth is fueled by an increasing emphasis on early HIV detection, rising HIV prevalence, and a global shift toward personal, confidential health solutions.

Over 100 countries have adopted HIVST policies, and more than 20 million kits were distributed globally in 2023 alone. The affordability and scalability of rapid diagnostic kits have made them integral in both developed and developing health systems. As of the most recent estimates, approximately 40.8 million people worldwide are living with HIV, including 1.4 million children between the ages of 0 and 14. In 2024 alone, there were about 1.3 million new HIV infections, with 120,000 cases occurring in children. That same year, an estimated 630,000 people died from HIV-related causes, including 75,000 children. Since the beginning of the HIV epidemic, it is estimated that 44.1 million people have lost their lives due to HIV-related illnesses. Despite the ongoing impact, global progress has been substantial over the past decade and a half. Between 2010 and 2024, the number of new HIV infections decreased by approximately 40%, dropping from 2.2 million to 1.3 million annually. During the same period, HIV-related deaths fell by 54%, declining from 1.4 million to 630,000. These reductions reflect the success of widespread awareness, prevention efforts, antiretroviral therapy scale-up, and increasing adoption of strategies such as HIV self-testing, which have contributed to earlier diagnosis and treatment initiation.

One of the strongest drivers of the HIV self-testing market is the rising demand for discreet, accessible, and user-friendly diagnostic options, particularly in populations facing stigma or barriers to clinic-based testing. According to UNAIDS, nearly 40% of people living with HIV globally remain undiagnosed, a gap largely attributed to fear of discrimination, social stigma, and inconvenient access to health facilities. HIV self-tests provide a private, at-home alternative that empowers individuals to know their status without fear. Saliva-based kits such as OraQuick In-Home HIV Test have become popular for their non-invasive nature, simplicity, and 20-minute result window. In regions such as Sub-Saharan Africa, where HIV prevalence is highest, self-testing has been pivotal: countries like Kenya, Malawi, and South Africa have scaled up national HIVST programs through community and NGO distribution. In high-income countries, rising e-commerce penetration has enabled widespread access to HIV self-tests via online pharmacies. This combination of anonymity, convenience, and technological simplicity is not only improving diagnosis rates but also fundamentally shifting how public health systems approach HIV prevention and treatment linkage.

Technological advancements are transforming HIV self-testing into a more accurate, efficient, and user-centric process. The most common format-lateral flow immunoassays (LFA)-uses a simple strip that detects HIV-1/2 antibodies through a saliva or finger-prick blood sample. These tests deliver results in 15-20 minutes, and newer devices incorporate all-in-one integrated systems, such as Atomo's HIV Self-Test, which combines lancet, buffer, and strip in a single device. In addition, smartphone-linked digital self-tests are being piloted, allowing users to scan results, receive guided instructions, and access telehealth services-enhancing test reliability and post-test linkage to care. In clinical trials, smartphone-based readers have shown >98% concordance with trained visual interpretation. Furthermore, innovations in microfluidics and nano-based detection promise to make future HIVST kits even more sensitive and early-stage infection-aware. The industry is also shifting toward combination kits (e.g., HIV + syphilis), especially in areas with co-infection burdens. These technological improvements not only reduce human error but also make self-testing viable in low-literacy populations, further expanding its global reach.

Global HIV Self-testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global HIV self-testing market based on type, technology, distribution channel, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood-based Kits
  • Saliva-based Kits
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunofiltration Assays
  • Lateral Flow Assays (LFA)
  • Other Rapid Diagnostic Technologies
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Retail and Online Pharmacies
  • Hospitals and Diagnostics Laboratories
  • NGO/ Community-based Distribution
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. HIV Self-testing Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type Segment
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Sample Type segment
      • 1.1.1.4. Distribution Channel Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. HIV Self-testing Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Technology Snapshot
  • 2.3. Distribution Channel Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. HIV Self-testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising HIV awareness and government initiatives
    • 3.4.2. High demand for privacy and convenience
    • 3.4.3. Technological advancements in test kits
  • 3.5. Market Restraint Analysis
    • 3.5.1. Regulatory and approval challenges
    • 3.5.2. Risk of misuse or misinterpretation
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. HIV Self-testing Market: Type Estimates & Trend Analysis

  • 4.1. HIV Self-testing Market: Type Movement Analysis
  • 4.2. Blood-based Kits
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Saliva-based Kits
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. HIV Self-testing Market: Technology Estimates & Trend Analysis

  • 5.1. HIV Self-testing Market: Technology Movement Analysis
  • 5.2. Immunofiltration Assays
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Lateral Flow Assays (LFA)
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Other Rapid Diagnostic Technologies
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. HIV Self-testing Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. HIV Self-testing Market: Distribution Channel Movement Analysis
  • 6.2. Retail and Online Pharmacies
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Hospitals and Diagnostics Laboratories
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. NGO/Community-Based Distribution
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. HIV Self-testing Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America HIV Self-testing Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe HIV Self-testing Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific HIV Self-testing Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America HIV Self-testing Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA HIV Self-testing Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. OraSure Technologies, Inc.
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. BioSURE HIVST
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Atomo Diagnostics
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Chembio Diagnostics, Inc.
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. SD Biosensor, INC.
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. CTK Biotech, Inc.
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. genedrive plc
      • 8.5.8.1. Company Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Hydrex Diagnostics Sp.
      • 8.5.9.1. Company Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Trinity Biotech
      • 8.5.10.1. Company Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Abbott
      • 8.5.11.1. Company Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviation
  • Table 3 Global HIV Self-testing Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 5 Global HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 Global HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 7 North America HIV Self-testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 9 North America HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 10 North America HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 11 U.S. HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 12 U.S. HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 13 U.S. HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 14 Canada HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 Canada HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 Canada HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 17 Mexico HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 18 Mexico HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 19 Mexico HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 20 Europe HIV Self-testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 22 Europe HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 23 Europe HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 24 UK HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 25 UK HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 26 UK HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 27 Germany HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Germany HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 Germany HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 30 France HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 31 France HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 32 France HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 33 Italy HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 34 Italy HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 35 Italy HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 36 Spain HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 37 Spain HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 38 Spain HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 39 Sweden HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 Sweden HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 41 Sweden HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 42 Norway HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 43 Norway HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 44 Norway HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 45 Denmark HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 46 Denmark HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 47 Denmark HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific HIV Self-testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 52 Japan HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 53 Japan HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 54 Japan HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 55 China HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 China HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 China HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 58 India HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 59 India HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 60 India HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 61 Australia HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 62 Australia HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 63 Australia HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 64 Thailand HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 Thailand HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 66 Thailand HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 67 South Korea HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 68 South Korea HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 69 South Korea HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 70 Latin America HIV Self-testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 72 Latin America HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 73 Latin America HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 74 Brazil HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 75 Brazil HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 76 Brazil HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 77 Argentina HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 78 Argentina HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 79 Argentina HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 80 MEA HIV Self-testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 81 MEA HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 82 MEA HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 83 MEA HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 84 South Africa HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 85 South Africa HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 86 South Africa HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 90 UAE HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 91 UAE HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 92 UAE HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 93 Kuwait HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 95 Kuwait HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global HIV self-testing market- Key market driver analysis
  • Fig. 7 Global HIV self-testing market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global HIV self-testing market - Porter's analysis
  • Fig. 10 Global HIV self-testing market - PESTEL analysis
  • Fig. 11 Global HIV self-testing market Type outlook key takeaways
  • Fig. 12 Global HIV self-testing market: Type movement analysis
  • Fig. 13 Blood-based kits market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Saliva-based kits market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 HSV-1 market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 HSV-2 market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Global HIV self-testing market technology outlook key takeaways
  • Fig. 18 Global HIV self-testing market: technology movement analysis
  • Fig. 19 Immunofiltration Assays market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Lateral flow assays (LFA) market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Other rapid diagnostic technologies market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Global HIV self-testing market distribution channel outlook key takeaways
  • Fig. 23 Global HIV self-testing market: distribution channel movement analysis
  • Fig. 24 Retail and online pharmacies market estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Hospitals and diagnostics laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 NGO/Community-based distribution market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 Global HIV Self-testing market: Regional movement analysis
  • Fig. 29 North America HIV Self-testing market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 31 Canada HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 33 Europe HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 34 UK HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 35 Germany HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 36 France HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 37 Spain HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 38 Italy HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 39 Denmark HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 40 Sweden HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 41 Norway HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 42 Asia Pacific HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 43 Japan HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 44 China HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 45 India HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 46 South Korea HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 47 Australia HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 48 Thailand HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 49 Latin America HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 50 Brazil HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 51 Argentina HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 52 MEA HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 53 South Africa HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 54 Saudi Arabia HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 55 UAE HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 56 Kuwait HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 57 Strategy framework